GGrantIndex
← Leaderboards

Carl Ola Landgren

Hoag Memorial Hospital Presbyterian

$1,820,254
Attributed
$3,796,086
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY201525
$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,025,797 · 2
CDC$1,492,289 · 2
FDA$278,000 · 1

By mechanism

R01$1,961,946 · 1
U01$1,770,289 · 3
P30$63,851 · 1

Top collaborators

Most similar at Hoag Memorial Hospital Presbyterian

Same institution · by research overlap

Others in their field

Top investigators on “Future

Research focus

FutureMultiple MyelomaLaboratoriesTreatment ResponseCombined Modality TherapyInnovationResearch PersonnelMemorial Sloan-Kettering Cancer CenterClinical ApplicationTumorPlasma CellsDesignMonoclonal AntibodiesEarly Phase TrialDosimetryFluorodeoxyglucose Positron Emission TomographyDetectionAntibodiesDetection Of Minimal Residual DiseaseFunding OpportunitiesBone Marrow BiopsyClinically SignificantBurden Of IllnessClinical Trials

Grant awards (18)

Translational and Clinical Oncology Research Program$34,499
P30 · FY2025 · CA · contact PI
CD38-TARGETED IMMUNOPET OF MYELOMA: PHASE 2 TRIAL OF CLINICAL APPLICATIONS$560,238
R01 · FY2024 · CA
Translational and Clinical Oncology Research Program$29,352
P30 · FY2024 · CA · contact PI
CD38-TARGETED IMMUNOPET OF MYELOMA: PHASE 2 TRIAL OF CLINICAL APPLICATIONS$577,160
R01 · FY2023 · CA
CD38-TARGETED IMMUNOPET OF MYELOMA: PHASE 2 TRIAL OF CLINICAL APPLICATIONS$50,000
R01 · FY2023 · CA
CD38-TARGETED IMMUNOPET OF MYELOMA: PHASE 2 TRIAL OF CLINICAL APPLICATIONS$40,000
R01 · FY2022 · CA
CD38-TARGETED IMMUNOPET OF MYELOMA: PHASE 2 TRIAL OF CLINICAL APPLICATIONS$598,926
R01 · FY2020 · CA
Myeloma Precursor Disease among WTC responders$492,618
U01 · FY2020 · OH
CD38-targeted immunoPET of myeloma: Phase 2 trial of clinical applications$135,622
R01 · FY2020 · CA
Early Detection of Hematologic Malignancies in New York City Firefighters Exposed To World Trade Center Dust After The 9/11 Attacks$499,807
U01 · FY2018 · OH
Early Detection of Hematologic Malignancies in New York City Firefighters Exposed To World Trade Center Dust After The 9/11 Attacks$499,864
U01 · FY2017 · OH
Molecular Characterization of Multiple Myeloma Ethnic Disparity$106,000
U01 · FY2016 · FD · contact PI
Molecular Characterization of Multiple Myeloma Ethnic Disparity$172,000
U01 · FY2015 · FD · contact PI
Molecular and clinical profiling$1,125,632
ZIA · FY2011 · CA · contact PI
Population based studies$198,641
ZIA · FY2011 · CA · contact PI
Molecular and clinical profiling$551,509
ZIA · FY2010 · CA · contact PI
Population based studies$97,324
ZIA · FY2010 · CA · contact PI
Population based studies$80,965
ZIA · FY2009 · CA · contact PI